INTRODUCTION- This compound belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic
.
MECHANISM OF ACTION-
* Dextromethorphan is an opioid-like drug that binds to and acts as antagonist to the NMDA glutamatergic receptor, it is an agonist to the opioid sigma 1 and sigma 2 receptors, it is also an alpha3/beta4 nicotinic receptor antagonist and targets the serotonin reuptake pump.
PHARMACOKINETICS-
* Dextromethorphan is rapidly absorbed from the gastrointestinal tract, where it enters the bloodstream and crosses the blood-brain barrier.
* The first-pass through the hepatic portal vein results in some of the drug being metabolized into an active metabolite of dextromethorphan, dextrorphan, the 3-hydroxy derivative of dextromethorphan.
HALF LIFE-3-6 hours
DRUG-DRUG INTERACTIONS-
* DEXTROMETHORPHAN+ ABIRATERONE= The serum concentration of Dextromethorphan can be increased.
* DEXTROMETHORPHAN+ ACEPROMAZINE= The risk or severity of adverse effects can be increased.
* DEXTROMETHORPHAN+ AMIODARONE=The metabolism of Dextromethorphan can be decreased.
SIDE EFFECTS-
* severe dizziness, anxiety, restless feeling, or nervousness;
* confusion, hallucinations; or
* slow, shallow breathing.
* Stomach upset
THERAPEUTIC USES-
* For the treatment of dry cough.
* It is a cough suppressant. It affects the signals in the brain that trigger cough reflex.
REFERENCE: Tripathi K.D, "Essentials of medical pharmacology", Edition 7th, page no.-217, 220,221
No comments:
Post a Comment